AP
FDA panel reviews Pfizer's COVID vaccine for kids
From the Watch Now: Nor'easter floods roads in New York City, and more of today's top videos series
U.S. health advisers are deliberating whether kid-size doses of Pfizer's COVID-19 vaccine are safe and effective for 5- to 11-year-olds. Tuesday's meeting of the Food and Drug Administration panel is the first step toward expanding vaccinations to 28 million young children.
As featured on
Drivers and pedestrians maneuvered through flooded roads as a Nor'Easter soaked New York Cit…
